fda compounding semaglutide news today The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the FDA crackdown on off-brand Ozempic

That includes adults with obesity, or some overweight adults who also have at least one weight-related condition, such as type 2 diabetes, high blood pressure, or obstructive sleep apnea

Samples were trimmed and cut en face with a diamond knife (DiATOME) in a Leica Ultracut UCT 6 ultramicrotome before examination on an FEI Tecnai G2-Spirit TEM

Analytical Quality Manufactured under rigorous quality control standards and tested using HPLC and LC-MS protocols to support purity evaluation, analytical confidence, formulation consistency, and reproducible laboratory research

The structural modification in Fragment 176-191 is theorized to support its affinity for particular molecular targets without engaging in broader physiological functions typically associated with its parent peptide